Connection

Solange Peters to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Solange Peters has written about Protein Kinase Inhibitors.
Solange Peters
Connection Strength
0.420
Protein Kinase Inhibitors
  1. Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer. N Engl J Med. 2017 08 31; 377(9):829-838.
    View in: PubMed
    Score: 0.331
  2. Management of Resistance to First-Line Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitor Therapy. Curr Treat Options Oncol. 2018 05 28; 19(7):37.
    View in: PubMed
    Score: 0.089
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.